Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell-Free Screening, Production and Animal Testing of a STI-Related Chlamydial Major Outer Membrane Protein Supported in Nanolipoproteins.
Mohagheghi M, Abisoye-Ogunniyan A, Evans AC, Peterson AE, Bude GA, Hoang-Phou S, Vannest BD, Hall D, Rasley A, Weilhammer DR, Fischer NO, He W, Robinson BV, Pal S, Slepenkin A, de la Maza L, Coleman MA. Mohagheghi M, et al. Among authors: rasley a. Vaccines (Basel). 2024 Nov 1;12(11):1246. doi: 10.3390/vaccines12111246. Vaccines (Basel). 2024. PMID: 39591149 Free PMC article.
CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in Mice.
Hoang-Phou S, Pal S, Slepenkin A, Abisoye-Ogunniyun A, Zhang Y, Gilmore SF, Shelby ML, Bourguet FA, Mohagheghi MV, Noy A, Rasley A, de la Maza LM, Coleman MA. Hoang-Phou S, et al. Among authors: rasley a. Vaccines (Basel). 2024 Oct 3;12(10):1134. doi: 10.3390/vaccines12101134. Vaccines (Basel). 2024. PMID: 39460301 Free PMC article.
Evaluation in mice of cell-free produced CT584 as a Chlamydia vaccine antigen.
Hoang-Phou S, Pal S, Slepenkin A, Abisoye-Ogunniyun A, Zhang Y, Gilmore SF, Shelby M, Bourguet F, Mohagheghi M, Noy A, Rasley A, de la Maza LM, Coleman MA. Hoang-Phou S, et al. Among authors: rasley a. bioRxiv [Preprint]. 2024 Jun 6:2024.06.04.597210. doi: 10.1101/2024.06.04.597210. bioRxiv. 2024. PMID: 38895407 Free PMC article. Preprint.
Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum respiratory challenge.
de la Maza L, Slepenkin A, Pal S, Rasley A, Coleman M. de la Maza L, et al. Among authors: rasley a. Res Sq [Preprint]. 2023 Dec 11:rs.3.rs-3688658. doi: 10.21203/rs.3.rs-3688658/v1. Res Sq. 2023. Update in: NPJ Vaccines. 2024 Jun 10;9(1):104. doi: 10.1038/s41541-024-00880-6 PMID: 38168233 Free PMC article. Updated. Preprint.
The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane Protein to Elicit Protective Immune Responses against a Chlamydia muridarum Respiratory Challenge.
Slepenkin A, Pal S, Hoang-Phou S, Abisoye-Ogunniyan A, Rasley A, D'haeseleer P, Coleman MA, de la Maza LM. Slepenkin A, et al. Among authors: rasley a. Vaccines (Basel). 2023 Feb 21;11(3):504. doi: 10.3390/vaccines11030504. Vaccines (Basel). 2023. PMID: 36992088 Free PMC article.
40 results